Impact of Vincristine Dose Reduction on Outcomes of Patients With Advanced-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP. (PubMed, Eur J Haematol) - Sep 17, 2026 - "Selective vincristine dose reduction due to VIPN was not associated with inferior progression-free or OS in patients with DLBCL treated with R-CHOP. These findings support vincristine dose reduction for management of VIPN while maintaining adequate doxorubicin dose intensity."
Journal • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Pain
|
|
Aurelia H de Vries Schultink; Berber A Zweers; Eva de Jongh; Jantina P Kortleve; Karolina Sikorska; Maaike Söhne; Marcel P H van den Broek; Mark-David Levin; Peter E Westerweel; Sofie Engels; Yasmina Serroukh
|